Rainer Schmeidl

Rainer Schmeidl has a strong background in drug safety and pharmacovigilance. Rainer began their career at Hoechst in 1990 as a Corporate Drug Safety Project Manager. Rainer then moved to Hoechst-Marion-Roussel GmbH, where they held the position of Head of Drug Safety and Pharmacovigilance for HMR Germany. Rainer later joined Aventis Pharma Deutschland GmbH, where they served as Head of Drug Safety and Pharmacovigilance. In 2004, they joined Merck KGaA as VP of Corporate Drug Safety. Rainer then went on to work for Biotest AG as VP of Corporate Drug Safety and Pharmacovigilance.

Rainer Schmeidl earned their MD and PhD degrees in Medicine from Goethe University Frankfurt between 1975 and 1984.